Tag: Tisotumab vedotin approval

Home / Tisotumab vedotin approval

Categories

Tisotumab vedotin-tftv is approved by the FDA for recurrent or metastatic cervical cancer

April 2024: Tisotumab vedotin-tftv (Tivdak, Seagen Inc. [now a part of Pfizer Inc.]) has received formal approval from the Food and Drug Administration for the treatment of recurrent or metastatic cer...
tisotumab-vedotin-approval

We Are Online! Chat With Us!
Scan the code